435 related articles for article (PubMed ID: 10805767)
1. Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide.
Boger DL; Sato H; Lerner AE; Hedrick MP; Fecik RA; Miyauchi H; Wilkie GD; Austin BJ; Patricelli MP; Cravatt BF
Proc Natl Acad Sci U S A; 2000 May; 97(10):5044-9. PubMed ID: 10805767
[TBL] [Abstract][Full Text] [Related]
2. alpha-Keto heterocycle inhibitors of fatty acid amide hydrolase: carbonyl group modification and alpha-substitution.
Boger DL; Miyauchi H; Hedrick MP
Bioorg Med Chem Lett; 2001 Jun; 11(12):1517-20. PubMed ID: 11412972
[TBL] [Abstract][Full Text] [Related]
3. Fatty acid amide hydrolase: biochemistry, pharmacology, and therapeutic possibilities for an enzyme hydrolyzing anandamide, 2-arachidonoylglycerol, palmitoylethanolamide, and oleamide.
Fowler CJ; Jonsson KO; Tiger G
Biochem Pharmacol; 2001 Sep; 62(5):517-26. PubMed ID: 11585048
[TBL] [Abstract][Full Text] [Related]
4. Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase.
Bisogno T; Melck D; De Petrocellis L; Bobrov MYu ; Gretskaya NM; Bezuglov VV; Sitachitta N; Gerwick WH; Di Marzo V
Biochem Biophys Res Commun; 1998 Jul; 248(3):515-22. PubMed ID: 9703957
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and biological properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a mechanism-based inhibitor of fatty acid amide hydrolase.
Karbarz MJ; Luo L; Chang L; Tham CS; Palmer JA; Wilson SJ; Wennerholm ML; Brown SM; Scott BP; Apodaca RL; Keith JM; Wu J; Breitenbucher JG; Chaplan SR; Webb M
Anesth Analg; 2009 Jan; 108(1):316-29. PubMed ID: 19095868
[TBL] [Abstract][Full Text] [Related]
6. Potent and selective alpha-ketoheterocycle-based inhibitors of the anandamide and oleamide catabolizing enzyme, fatty acid amide hydrolase.
Romero FA; Du W; Hwang I; Rayl TJ; Kimball FS; Leung D; Hoover HS; Apodaca RL; Breitenbucher JG; Cravatt BF; Boger DL
J Med Chem; 2007 Mar; 50(5):1058-68. PubMed ID: 17279740
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo.
Lichtman AH; Hawkins EG; Griffin G; Cravatt BF
J Pharmacol Exp Ther; 2002 Jul; 302(1):73-9. PubMed ID: 12065702
[TBL] [Abstract][Full Text] [Related]
8. Oleamide: a fatty acid amide signaling molecule in the cardiovascular system?
Hiley CR; Hoi PM
Cardiovasc Drug Rev; 2007; 25(1):46-60. PubMed ID: 17445087
[TBL] [Abstract][Full Text] [Related]
9. Fatty acid amide hydrolase, an enzyme with many bioactive substrates. Possible therapeutic implications.
Bisogno T; De Petrocellis L; Di Marzo V
Curr Pharm Des; 2002; 8(7):533-47. PubMed ID: 11945157
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of paracetamol esters as novel fatty acid amide hydrolase inhibitors.
Onnis V; Congiu C; Björklund E; Hempel F; Söderström E; Fowler CJ
J Med Chem; 2010 Mar; 53(5):2286-98. PubMed ID: 20143779
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.
Fegley D; Gaetani S; Duranti A; Tontini A; Mor M; Tarzia G; Piomelli D
J Pharmacol Exp Ther; 2005 Apr; 313(1):352-8. PubMed ID: 15579492
[TBL] [Abstract][Full Text] [Related]
12. Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor.
Deutsch DG; Lin S; Hill WA; Morse KL; Salehani D; Arreaza G; Omeir RL; Makriyannis A
Biochem Biophys Res Commun; 1997 Feb; 231(1):217-21. PubMed ID: 9070252
[TBL] [Abstract][Full Text] [Related]
13. Biosynthesis and degradation of bioactive fatty acid amides in human breast cancer and rat pheochromocytoma cells--implications for cell proliferation and differentiation.
Bisogno T; Katayama K; Melck D; Ueda N; De Petrocellis L; Yamamoto S; Di Marzo V
Eur J Biochem; 1998 Jun; 254(3):634-42. PubMed ID: 9688276
[TBL] [Abstract][Full Text] [Related]
14. The sleep inducing factor oleamide is produced by mouse neuroblastoma cells.
Bisogno T; Sepe N; De Petrocellis L; Mechoulam R; Di Marzo V
Biochem Biophys Res Commun; 1997 Oct; 239(2):473-9. PubMed ID: 9344854
[TBL] [Abstract][Full Text] [Related]
15. Fatty acid amide hydrolase inhibitors--progress and potential.
Khanna IK; Alexander CW
CNS Neurol Disord Drug Targets; 2011 Aug; 10(5):545-58. PubMed ID: 21631410
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of the sleep-inducing lipid oleamide and cannabinoids on the induction of long-term potentiation in the CA1 neurons of the rat hippocampus in vitro.
Lees G; Dougalis A
Brain Res; 2004 Jan; 997(1):1-14. PubMed ID: 14715144
[TBL] [Abstract][Full Text] [Related]
17. Fatty acid amide hydrolase inhibition by neurotoxic organophosphorus pesticides.
Quistad GB; Sparks SE; Casida JE
Toxicol Appl Pharmacol; 2001 May; 173(1):48-55. PubMed ID: 11350214
[TBL] [Abstract][Full Text] [Related]
18. A hydrolase enzyme inactivating endogenous ligands for cannabinoid receptors.
Ueda N; Goparaju SK; Katayama K; Kurahashi Y; Suzuki H; Yamamoto S
J Med Invest; 1998 Aug; 45(1-4):27-36. PubMed ID: 9864962
[TBL] [Abstract][Full Text] [Related]
19. The cellular uptake of anandamide is coupled to its breakdown by fatty-acid amide hydrolase.
Deutsch DG; Glaser ST; Howell JM; Kunz JS; Puffenbarger RA; Hillard CJ; Abumrad N
J Biol Chem; 2001 Mar; 276(10):6967-73. PubMed ID: 11118429
[TBL] [Abstract][Full Text] [Related]
20. A spectrophotometric assay for fatty acid amide hydrolase suitable for high-throughput screening.
De Bank PA; Kendall DA; Alexander SP
Biochem Pharmacol; 2005 Apr; 69(8):1187-93. PubMed ID: 15794939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
